SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (42404)10/30/2014 10:32:30 PM
From: Biomaven  Respond to of 52153
 
Well Neff has extracted close on $700m to date from Astellas and AstraZeneca in upfronts and equity investments, so they haven't needed to raise much from other investors.

But their programs overall have certainly moved very slowly for various reasons, so not really a dramatic return to early investors given the time delay.

Peter